BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$252.98
+1.63%Forward multiples
Based on analyst estimates
- P/E forward
- 17.13x
- P/E 2026E
- 20.01x
- P/E 2027E
- 15.34x
- P/E 2028E
- 13.61x
- P/S forward
- 3.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- 107.19x
- PEG TTM
- 0.20x
- Price / book
- 1.98x
- Price / sales
- 3.63x
- Price / cash flow
- 16.64x
Enterprise value
- Enterprise value
- $43.9B
- EV / sales
- 4.26x
- EV / EBITDA
- 30.30x
- EV / EBIT
- 55.78x
- Market cap
- $37.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026